Orthofix Medical (OFIX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual meeting scheduled for June 10, 2026, at 8:00 AM CDT in Plano, TX.
Shareholders of record as of April 13, 2026, are eligible to vote.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report, are available online.
Voting matters and shareholder proposals
Election of ten director nominees is on the agenda.
Advisory, non-binding vote to approve executive compensation is included.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan is proposed.
Board unanimously recommends voting FOR all director nominees and FOR proposals 2, 3, and 4.
Board of directors and corporate governance
Ten individuals nominated for election to the board.
Board's recommendations are unanimous for all proposals.
Latest events from Orthofix Medical
- Q1 2026 saw 3% pro forma sales growth, margin gains, and reaffirmed guidance with improved net loss.OFIX
Q1 20265 May 2026 - Annual meeting covers director elections, pay, auditor, and stock plan, with strong governance and ESG focus.OFIX
Proxy filing29 Apr 2026 - Margin expansion and innovation pipeline position the business for sustained, profitable growth.OFIX
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Growth momentum, channel optimization, and innovation set the stage for long-term value creation.OFIX
2026 CG Musculoskeletal Conference2 Mar 2026 - Q4 and 2025 saw strong sales and margin gains, with 2026 guidance targeting further growth.OFIX
Q4 202524 Feb 2026 - Q2 sales up 6% year-over-year; full-year guidance raised on strong segment growth.OFIX
Q2 20242 Feb 2026 - Innovative technology and operational focus drive above-market growth and financial strength.OFIX
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase2 Feb 2026 - Q3 2024 net sales up 7% to $196.6M, with margin gains and new $275M credit facility secured.OFIX
Q3 202416 Jan 2026 - Transformation and profitable growth driven by leadership, innovation, and operational discipline.OFIX
Stifel 2024 Healthcare Conference13 Jan 2026